Joe Daccache: The largest multimodal foundation models in Oncology
Joe Daccache, Corporate Development at Pathos AI, shared a post on LinkedIn:
“Big news from the Pathos team!
We’re teaming up with Tempus AI and AstraZeneca to build one of the largest multimodal foundation models in oncology — and we couldn’t be more excited.
This collaboration is about more than just AI and data (though there’s a lot of both!). It’s about building something that could truly change how we understand and treat cancer. Together, we’re combining deep scientific expertise, vast oncology datasets, and a shared goal: to improve the way new treatments are discovered and developed.
With Tempus’ world-class data, AstraZeneca’s global reach in therapeutics, and our growing platform at Pathos, we’re aiming to move the needle in oncology research. At Pathos, we’ve always believed that the future of drug discovery will be shaped by data — thoughtfully applied. Working with partners who bring complementary strengths makes this all the more meaningful.
We’re excited for what’s ahead — and for the impact this can have across the oncology space.
Press Release.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023